AFSSI Digital Week - 16 October 2020 - 2pm - CEST

Infectious diseases are caused by pathogenic micro-organisms, such as bacteria, viruses, parasites or fungi; diseases can be transmitted, directly or indirectly, from one person to another.Infectious diseases are caused by pathogenic micro-organisms, such as bacteria, viruses, parasites or fungi; diseases can be transmitted, directly or indirectly, from one person to another.

Three infectious diseases have been ranked among the top ten causes of death worldwide in 2016 by the World Health Organization. These are lower respiratory tract infections (3.0 million deaths), diarrhoeal diseases (1.4 million deaths) and tuberculosis (1.3 million deaths). 

Despite significant progress in research and treatments for infectious diseases, the control and eradication of these diseases still face major challenges.
We are currently facing a new emerging infectious disease with the global COVID-19 outbreak caused by the SARS-CoV-2 virus, a type of coronavirus part of a group of RNA viruses (that cause diseases in mammals and birds). Both public research and pharmaceutical industry have been mobilized to find ways to speed up the launch of prophylactic or therapeutic solutions. We have to be SMART to win the race against COVID-19. Different options can be considered, such as substantial investments, drug repositioning, massive consolidation of pharmaceutical companies.

Faced with this fast-paced demand from the pharmaceutical industry, the CROs are coming together to respond quickly and ingeniously to this unprecedented health crisis.

Come and listen to Innovative Providers’ solutions. We will unveil our continuum of specialties to unlock the scientific padlocks linked to Covid-19.

Key learning objectives

• Panorama of Emergent & Infectious Disease
• The ongoing COVID-19 outbreak
• Challenges to overcome ​to find a solution against Covid-19​
• Our scientific & smart specialties to keep you in the race

Discover our speakers

View the presentation on line